Cardiovascular Effects of Rapidly Declining Plasma Glucose in Patients With Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

December 16, 2021

Study Completion Date

April 1, 2023

Conditions
Type 1 Diabetes
Interventions
OTHER

Rapidly declining plasma glucose

Acute plasma glucose decline, divided into the following three phases: 1) Hyperglycaemic phase (plasma glucose 15 mmol/l), 2) Rapid plasma glucose decline phase and 3) Euglycaemic phase (plasma glucose 4.5-5.5 mmol/l).

OTHER

Slowly declining plasma glucose

Acute plasma glucose decline, divided into the following three phases: 1) Hyperglycaemic phase (plasma glucose 15 mmol/l), 2) Slow plasma glucose decline phase and 3) Euglycaemic phase (plasma glucose 4.5-5.5 mmol/l).

Trial Locations (1)

2900

Steno Diabetes Center Copenhagen - Gentofte Hospital, Copenhagen

All Listed Sponsors
collaborator

University Hospital, Gentofte, Copenhagen

OTHER

collaborator

Rigshospitalet, Denmark

OTHER

lead

Steno Diabetes Center Copenhagen

OTHER